Scarica l'app Stockscreener
5.70
2.40%
-0.14
Dopo l'orario di chiusura:
5.70
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Verastem Inc Borsa (VSTM) Ultime notizie
Verastem Oncology Reports Progress in Cancer Treatments - TipRanks
Verastem (NASDAQ:VSTM) Upgraded at StockNews.com - MarketBeat
Wall Street Analysts Believe Verastem (VSTM) Could Rally 100.94%: Here's is How to Trade - Yahoo Finance
(VSTM) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025 - Yahoo Finance
Verastem CFO Daniel Calkins sells shares worth $630 - Investing.com India
Verastem CFO Daniel Calkins sells shares worth $630 By Investing.com - Investing.com Australia
H.C. Wainwright lifts Verastem stock price target to $10 By Investing.com - Investing.com Canada
Guggenheim lifts Verastem stock target to $14, maintains buy By Investing.com - Investing.com Canada
H.C. Wainwright lifts Verastem stock price target to $10 - Investing.com India
Royal Bank of Canada Lowers Verastem (NASDAQ:VSTM) Price Target to $14.00 - Defense World
RBC Cuts Price Target on Verastem to $14 From $16, Maintains Outperform Rating -March 21, 2025 at 08:40 am EDT - Marketscreener.com
BTIG maintains $20 target, Buy rating on Verastem stock By Investing.com - Investing.com Canada
Verastem: Q4 Earnings Snapshot - Midland Daily News
Verastem director Brian Stuglik sells shares worth $4,121 By Investing.com - Investing.com Australia
Verastem Unveils Strategic Plans in New Presentation - TipRanks
Verastem Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Verastem, Inc. SEC 10-K Report - TradingView
Verastem Inc. (VSTM) reports earnings - Quartz
Verastem Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates - Bluefield Daily Telegraph
Verastem director Robert Gagnon sells shares worth $1,973 By Investing.com - Investing.com Australia
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Verastem, Inc. (NASDAQ:VSTM) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Verastem CEO sells shares worth $1,695 By Investing.com - Investing.com South Africa
Verastem director Robert Gagnon sells shares worth $1,973 - Investing.com
Verastem director Brian Stuglik sells shares worth $4,121 - Investing.com
Verastem (NASDAQ:VSTM) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World
Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Verastem Inc expected to post a loss of 81 cents a shareEarnings Preview - TradingView
Verastem to Present at Keystone Symposia on PI3 Kinase - AOL.com
Verastem: Upcoming PDUFA, But I Remain Cautious (NASDAQ:VSTM) - Seeking Alpha
Rhumbline Advisers Acquires 10,352 Shares of Verastem, Inc. (NASDAQ:VSTM) - Defense World
Why the Global Cancer Market Could Surpass $900 Billion-And the Stocks Leading the Charge - The Malaysian Reserve
Why the Global Cancer Market Could Surpass $900 Billion—And the Stocks Leading the Charge - Morningstar
Verastem (VSTM) Expected to Announce Earnings on Thursday - Defense World
Objective long/short (VSTM) Report - Stock Traders Daily
Verastem Inc (NASDAQ: VSTM) Stock Forecast: Bearish Expectations Portend -120.34% Downside In 2025 - Stocks Register
Verastem (NASDAQ:VSTM) Stock Price Passes Above 200 Day Moving Average – Should You Sell? - Defense World
Verastem, Inc. (NASDAQ:VSTM) Given Consensus Rating of “Buy” by Brokerages - Defense World
Verastem Oncology Announces Multiple Data Presentations At Society Of Gynecologic Oncology 2025 Annual Meeting On Women's Cancer - Marketscreener.com
Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer - Business Wire
VSTM Up as NDA for Ovarian Cancer Combo Gets FDA's Priority Review Tag - MSN
When the Price of (VSTM) Talks, People Listen - Stock Traders Daily
Financial Snapshot: Analyzing Verastem Inc (VSTM)’s Key Ratio Metrics - The Dwinnex
Verastem Inc (NASDAQ: VSTM) Shares Fall By -4.77 Percent In The Past Week, But How Long Will It Last? - Marketing Sentinel
1.23%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):